Zura Bio Limited (NasdaqCM: ZURA)
Health Care · Biotechnology · US
$4.17
+1.46% today · -1.4% 1Y
Zura Bio Limited (NasdaqCM: ZURA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $393.86M and employs 40 people.
Over the last twelve months the share price has lost 1.4%, trading between 3.15 and 7.44.
Tweenvest scores Zura Bio Limited across four factors: quality 55/100, value 58/100. Its strongest factor is value.
ZURA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $393.86M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.09
- Dividend yield
- —
- Beta (5Y)
- 0.01
- 52-week high
- $7.44
- 52-week low
- $3.15
- Avg volume (3M)
- —
- Shares outstanding
- 95.83M
- Employees
- 40
- Next earnings
- —
About Zura Bio Limited
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
- ISIN
- KYG9TY5A1016
- Founded
- 2022
- Listed since
- Mar 21, 2023
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbClon Inc.KOSDAQ: A174900 | $413.34M | ₩27,900.00 | +42.35% |
| Eikon Therapeutics, Inc.NasdaqGS: EIKN | $408.40M | $7.54 | +0.40% |
| Guangdong VTR Bio-Tech Co., Ltd.SZSE: 300381 | $407.32M | CN¥5.69 | +0.18% |
| ARS Pharmaceuticals, Inc.NasdaqGM: SPRY | $404.75M | $4.36 | +7.13% |
| AVITA Medical, Inc.NasdaqCM: RCEL | $393.39M | $13.05 | +2.59% |
| Galectin Therapeutics Inc.NasdaqCM: GALT | $393.31M | $3.62 | -7.18% |
| Kyverna Therapeutics, Inc.NasdaqGS: KYTX | $381.57M | $6.17 | +0.16% |
| vTv Therapeutics Inc.NasdaqCM: VTVT | $379.82M | $31.01 | +1.44% |
Figures last refreshed Oct 4, 2026.